Women and men are at different risks for disorders that occur at different stages of the lifespan from development through aging and have critical implications for therapeutic efficacy. However, many of the mechanisms that explain these sex differences or disorders specific to women are still unclear. The mission of our Harvard BIRCWH is to develop the next generation of scientist-clinicians as leaders in the field of women's health and sex differences who will contribute to understanding sex-dependent vulnerabilities to clinical disorders and those specific to women. This competing renewal application seeks to continue to support an integrated interdisciplinary training program that is based on a translational approach to understanding differential incidences of disorders important for the health of women and how it differs from men. The program is modeled in the context of a lifespan perspective to identify etiologic mechanisms during fetal development, puberty, adulthood, and aging, including the child-bearing years and menopause. Further, an underlying assumption of our BIRCWH program is that an understanding of the role of hormones and genes will provide the basis for understanding sex-dependent vulnerabilities to clinical disorders. The Division of Women's Health at Brigham and Women's Hospital (BWH) and the Women, Heart and Brain Global Initiative at Massachusetts General Hospital (MGH) Research Institute, are the home sites for this endeavor, in the broader context of a Harvard-wide training program. The program capitalizes on the long tradition of interdisciplinary research in women's health and sex differences with mentors across Harvard institutions: BWH, MGH, Beth Israel- Deaconess Medical Center, Boston Children's Hospital, Dana Farber Cancer Institute, McLean Hospital, Harvard T.H. Chan School of Public Health, Harvard Medical School and the Eli & Edythe Broad Institute. Each BIRCWH scholar is assigned a team of mentors to operationalize translational thinking. Primary Mentors are in clinical or basic research and provide the site at which the scholar works. Secondary Mentors are in basic or clinical research (as a counterpart to the Primary) and help to guide thinking, coursework and readings, depending on the scholar's interests. Career Mentors advise scholars in the relevant departmental and academic structures for career advancement. Mentors in Health Disparities expose scholars to thinking about how the roles of hormones and genes in affected morbidity are influenced by socioenvironmental factors. The Harvard BIRCWH program focuses on disorders with higher incidence and/or differential expression in women than men including: Cardiovascular Disorders; Reproductive Endocrine & Neuroendocrine Disorders; Neuropsychiatric Disorders; Autoimmune Disorders; and Female Cancers. By capitalizing on the vast resources and faculty at Harvard and our 14-year successful BIRCWH history, Harvard is an ideal site for continuing to offer an integrated, interdisciplinary and truly translational program that will continue to train the next generation of leaders in women's health and sex differences in medicine.

Public Health Relevance

Although there are significant sex differences in the expression and onset of major medical and psychiatric disorders, clinical decisions based on research are primarily based on data from men and may often be inappropriate for women. Thus, there remains a strong need for the Harvard BIRCWH program to educate, train, and develop junior investigators who will commit their careers to studying the impact of sex and gender on clinical disorders. Our Harvard BIRCWH program will provide the basis for the development of sex- dependent treatment approaches and public awareness of the importance of these sex-dependent health issues for families and society.

Agency
National Institute of Health (NIH)
Institute
Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)
Type
Physician Scientist Award (Program) (PSA) (K12)
Project #
2K12HD051959-16
Application #
9938066
Study Section
Special Emphasis Panel (ZRG1)
Program Officer
Begg, Elizabeth
Project Start
2005-09-01
Project End
2025-04-30
Budget Start
2020-08-01
Budget End
2021-04-30
Support Year
16
Fiscal Year
2020
Total Cost
Indirect Cost
Name
Brigham and Women's Hospital
Department
Type
DUNS #
030811269
City
Boston
State
MA
Country
United States
Zip Code
02115
James-Todd, Tamarra; March, Melissa I; Seiglie, Jacqueline et al. (2018) Racial differences in neonatal hypoglycemia among very early preterm births. J Perinatol 38:258-263
Gray, Kathryn J; Saxena, Richa; Karumanchi, S Ananth (2018) Genetic predisposition to preeclampsia is conferred by fetal DNA variants near FLT1, a gene involved in the regulation of angiogenesis. Am J Obstet Gynecol 218:211-218
Plessow, Franziska; Marengi, Dean A; Perry, Sylvia K et al. (2018) Effects of Intranasal Oxytocin on the Blood Oxygenation Level-Dependent Signal in Food Motivation and Cognitive Control Pathways in Overweight and Obese Men. Neuropsychopharmacology 43:638-645
Bove, Riley; Healy, Brain C; Musallam, Alexander et al. (2018) Fatty acid binding protein-4 is associated with disability in multiple sclerosis patients. Mult Scler :1352458517750768
Bove, Riley M; Patrick, Ellis; Aubin, Cristin McCabe et al. (2018) Reproductive period and epigenetic modifications of the oxidative phosphorylation pathway in the human prefrontal cortex. PLoS One 13:e0199073
Bellavia, Andrea; Cantonwine, David E; Meeker, John D et al. (2018) Pregnancy urinary bisphenol-A concentrations and glucose levels across BMI categories. Environ Int 113:35-41
Pace, Lydia E; Chen, Grace L; Chai, Jaclyn et al. (2018) Advancing Sex- and Gender-Informed Approaches to Health in an Academic Medical Center. Womens Health Issues 28:117-121
Dichtel, Laura E; Lawson, Elizabeth A; Schorr, Melanie et al. (2018) Neuroactive Steroids and Affective Symptoms in Women Across the Weight Spectrum. Neuropsychopharmacology 43:1436-1444
Konno, T; Miura, T; Harriott, A M et al. (2018) Partial loss of function of colony-stimulating factor 1 receptor in a patient with white matter abnormalities. Eur J Neurol 25:875-881
Bravo, Paco E; Bergmark, Brian A; Vita, Tomas et al. (2018) Diagnostic and prognostic value of myocardial blood flow quantification as non-invasive indicator of cardiac allograft vasculopathy. Eur Heart J 39:316-323

Showing the most recent 10 out of 137 publications